Induction of CD4+ and CD8+ T cell-mediated immunity, another fundamental arm of the adaptive immune system, has been associated with reduced COVID-19 disease severity (16, 17), but is far less well characterized than humoral reactivity to SARS-CoV-2 vaccination. The gene discussed is CD8A; the disease is COVID-19.